文献速递肝胆胰外科围术期管理与 ERAS

开放胰腺切除术后重复与单次腰方肌阻滞减少阿片类药物的随机临床试验

Repeat Versus Single Quadratus Lumborum Block to Reduce Opioids After Open Pancreatectomy (RESQU-BLOCK): A Randomized Clinical Trial.
PubMed 文献 · Ann Surg · 2025-05-27

单中心非盲II期随机试验纳入106例开放胰腺切除术患者,1:1分为标准化镇痛方案加或不加POD4补救阻滞。意向性分析显示第二阻滞组52%无阿片出院,单次阻滞组36.5%,出院口服吗啡当量中位数分别为0与25 mg,第二阻滞组出院及1个月疼痛与生活干扰评分更优,但差异未达显著。

要点

  • 开放胰腺切除术后加用POD4补救腰方肌阻滞未显著提高无阿片出院比例
  • 单次阻滞方案下仍有超过三分之一患者可无阿片出院
  • 补救阻滞组出院及1个月患者报告疼痛与生活干扰评分更优

核心结论

  • 在开放胰腺切除术后的阿片减量方案中加用第二次补救腰方肌阻滞未显著改善无阿片出院,且无需要即可使超过三分之一患者无阿片出院。
  • 考虑症状评分改善及无阿片出院的高门槛,以补救阻滞有目的性减至零使用的概念可行。

研究设计与样本

  • 单中心、非盲、II期随机临床试验,按意向性治疗及事后贝叶斯分析。
  • 106例开放胰腺切除术患者1:1随机接受标准化镇痛方案加或不加POD4补救阻滞,104例完成试验(每组52例)。
  • 人群特征:女性44.3%,中位年龄66.5岁,84%行胰十二指肠切除术,中位住院5天。

主要发现

  • 意向性治疗分析中,第二阻滞组52%无阿片出院,单次阻滞组36.5%。
  • 出院口服吗啡当量中位数第二阻滞组为0,单次阻滞组为25 mg。
  • 第二阻滞组在出院时及1个月的患者报告疼痛与生活干扰评分更优(更低)。

关键数值与推荐

  • 历史出院阿片处方为300 mg OME,仅5%患者无阿片出院。
  • 主要终点为无阿片出院比例,次要终点包括出院处方口服吗啡当量及患者报告结局。

临床怎么用

  • 开放胰腺切除术后可采用标准化镇痛方案,单次腰方肌阻滞即可使部分患者无阿片出院。
  • 对症状负担较重者,可考虑POD4补救阻滞以辅助逐步减至零阿片使用。

局限性

  • 单中心、非盲设计。
  • 样本量106例,主要终点差异未达显著。
  • 事后贝叶斯分析为探索性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The primary aim was to compare the proportion of opioid-free discharges between 2 postoperative analgesia bundles distinguished by receipt of a single-block versus a second, "rescue" block. Secondary outcomes included differences in discharge prescription oral morphine equivalents (OME) and patient-reported outcomes. BACKGROUND: After a preoperative quadratus lumborum block, our historical discharge opioid prescription for open pancreatectomy was 300 mg OME, with only 5% patients discharged opioid-free. We hypothesized an opioid-reduction bundle with repeat block on postoperative day (POD)4 could increase opioid-free discharges while reducing symptom burden. METHODS: This was a single-institution, unblinded phase II randomized clinical trial, analyzed by intention-to-treat and post hoc Bayesian analyses. Patients undergoing open pancreatectomy were randomized 1:1 to receive a standardized analgesic bundle with or without the addition of the rescue-block on POD4. RESULTS: Among 106 patients randomized (44.3% female; median age 66.5 years; 84% pancreatoduodenectomy; median 5-day stay), 104 completed the trial (52 per arm). By intention-to-treat, 52% of second-block patients were discharged opioid-free versus 36.5% single-block. Median discharge OME was 0 versus 25 mg, respectively. Improved (lower) patient-reported pain and life interference scores were observed in the second-block arm at discharge and 1 month. CONCLUSIONS: Addition of a second, "rescue" block to an opioid reduction bundle did not significantly improve opioid-free discharges after open pancreatectomy and was not required to discharge >1/3 of patients opioid-free. Nevertheless, considering improvements in symptom inventory and the high threshold of opioid-free discharge, the concept of a rescue-block to purposefully wean patients to zero use is feasible.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Fields BC, Soliz JM, Speer BB, et al. Repeat Versus Single Quadratus Lumborum Block to Reduce Opioids After Open Pancreatectomy (RESQU-BLOCK): A Randomized Clinical Trial. Ann Surg. 2025. PMID: 40421798. doi:10.1097/SLA.0000000000006767

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。